Since 2006, the Clinical Training Center for Sexual and Reproductive Health (CTC-SRH) has developed and delivered high-quality, evidence-based clinical training and shared skill development resources to Title X service providers. We have been funded by the Office of Population Affairs at the Department of Health and Human Services since inception. Read more.
For over 17 years, our mission has remained to offer the best clinical training to the nation’s Title X workforce. We do this by offering unique and accessible training such as live and on-demand webinars, e-learning, and onsite and virtual skills training. Many of our trainings are eligible for continuing education credits (CEs).
We host the National Reproductive Health Conference, the nation’s only annual conference for Title X clinicians, which is also open to non-Title X sexual and reproductive health providers. Next year’s conference will be entirely virtual and held from August 6th - 8th, 2025. We look forward to connecting with sexual and reproductive health clinicians from across the nation!
The CTC-SRH is funded by the Office of Population Affairs at the Department of Health and Human Services to deliver training and technical assistance to Title X family planning service grantees and providers. Formerly known as the National Clinical Training Center for Family Planning (NCTCFP), the CTC-SRH has continued to provide training and resources for Title X clinicians and the broader sexual and reproductive health provider workforce to increase quality, equity, and access in the healthcare field for over 17 years.
Recorded on October 1st, 2024, the CTC-SRH's own Dr. Kristin Metcalf-Wilson, Tammy Bennett, and Denise Raybon provide a comprehensive overview of the Syphilis Toolkit, followed by a discussion of practical applications of the toolkit resources.
This job aid assists the clinical provider with contraceptive considerations for transgender, nonbinary, and gender diverse (TNGD) patients assigned female at birth (AFAB). Special considerations are given for contraception for people on concurrent testosterone use, potential side effects, and menstrual suppression. Contraceptive methods are listed according to menstrual suppression, possibility of spotting/bleeding, cramping, breast tissue tenderness, and self-disclosure.
In this DIALS, recorded on September 26th, 2024, industry experts Dolores Connelly DeWitt and Sara Flubacher outline the current state of Mpox, as well as ACIP recommendation, the indications, and the availability of the vaccine, Jynneos.
This sample clinical protocol can be used to enhance clinicians' understanding of the appropriateness of expedited partner therapy (EPT) and how it can be used in communities with increasing gonorrhea and/or chlamydia rates by increasing treatment in underserved populations.
Instructions are provided within the template so local agencies can fully customize their organization's protocol. A web-accessible PDF is provided, along with an editable Word Document.
